Petino Tablets (Phenmetrazine Tartrate)

Adult dose

Administer 35 mg of Phenmetrazine Tartrate orally 2 to 3 times a day, one hour before meals. Use the minimum effective dose but adjust individually. For some patients, 17.5 mg once a day may be appropriate. Do not exceed 70 mg at a single dose or more than 3 times a day. Use for a short term (within 4 weeks). If satisfactory weight loss occurs within the first 4 weeks, treatment may be continued.

This drug must not be used in combination with other appetite suppressants due to the risk of serious heart problems. It is safest to be used alone for a short period for the treatment of exogenous obesity. The concomitant use of other medications for weight loss is not recommended as safety and efficacy have not been established. Using this drug for more than 3 months may significantly increase the risk of serious pulmonary conditions such as pulmonary arterial hypertension. If symptoms such as shortness of breath during exercise, chest pain, fainting, or leg swelling occur, discontinue the drug immediately and seek medical evaluation. This drug may be associated with valvular heart disease, so a heart condition must be confirmed before use, and individuals with poor heart status should not use it. This medication is not to be administered to those sensitive to sympathomimetics, individuals with atherosclerosis or cardiovascular diseases, hypertensive patients, those with hyperthyroidism, or those with glaucoma. People who are mentally unstable or in an excited state, as well as those with a history of substance abuse, should not use this drug. Concurrent use of central nervous system stimulants or MAO inhibitors may dangerously elevate blood pressure, so these should be avoided. Children under the age of 16 and pregnant or potentially pregnant women should not take this drug. Caution should be exercised in cases of mild hypertension, lactating women, and diabetic patients, and insulin dosage adjustments may be necessary for diabetic patients. While taking this medication, an increase in heart rate or blood pressure may occur, and neurological symptoms such as anxiety, dizziness, insomnia, and headaches may appear. Gastrointestinal symptoms such as dyspepsia, dry mouth, diarrhea, constipation, and changes in sexual desire, as well as urinary symptoms such as increased urination, are also reported. If tolerance to the medication develops, do not increase the dosage but discontinue its use, and take precautions when driving or operating hazardous machinery. In cases of overdose, symptoms may include anxiety, coma, seizures, abnormal blood pressure, and gastrointestinal disturbances, so the prescribed dosage must be strictly adhered to. Pregnant or nursing mothers should avoid taking this medication as its safety has not been established. This drug is classified as a narcotic and carries a risk of abuse; sudden cessation after prolonged high-dose use may lead to severe fatigue and depression. Therefore, it should be used cautiously according to a physician’s prescription and guidance, and stored out of the reach of children.

Serious side effects

• Hives
• exercise-induced dyspnea
• symptoms of angina
• fainting
• peripheral edema

Mild side effects

• Palpitations
• tachycardia
• increased blood pressure
• hyperstimulation
• anxiety
• dizziness
• insomnia
• tremors
• euphoria
• headaches

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature.

Appearance

White round tablet

Package unit

30 tablets/bottle, 300 tablets/bottle